The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday newspaper round-up: BAE Systems, Mark Carney, Japan...

Thu, 20th Dec 2012 06:51

The continued haggling with Saudi Arabia over the price of 48 Eurofighter Typhoon jets could hit full-year profits at BAE Systems. The British defence contractor said that negotiations with the Royal Saudi Air Force about the price of the aircraft may not be concluded before its results announcement in February. That could wipe 3p per share off underlying earnings, the company warned in a trading update yesterday. Analysts are forecasting earnings of about 40p per share, compared with 37p in 2011. [The Times]Incoming Bank of England governor Mark Carney will pocket an annual £250,000 housing allowance, taking his total pay package close to £1m a year when he takes the reins next summer, the central bank has revealed. Carney will receive the allowance as part of a generous package put together by the chancellor, George Osborne, to lure him from his current job in Ottawa as boss of the Canadian central bank. It was already known that Carney would be paid a salary of £480,000 and pension contributions worth £144,000. He will also receive free health and dental insurance and the use of a chauffeur-driven car.[The Guardian]The Bank of Japan has stepped up its monetary easing with a Y10tn ($118bn) increase in the size of its asset-purchasing programme, and signalled that it could move to adopt a higher inflation target, as requested by Shinzo Abe, the incoming prime minister. Mr Abe welcomed the BoJ's move, saying "what we called for during the Lower House election is being realised one by one." During the election campaign, he called for the BoJ to do more to combat persistent deflation by adopting "unlimited" easing and an inflation target of 2 per cent or more. [Financial Times]The Department of Justice has charged two former UBS traders with conspiracy to manipulate Libor, on the same day the Swiss banking giant agreed to pay £940m in fines to settle charges linked to the key global interest rate. Tom Alexander William Hayes, 33-year-old British former Tokyo-based trader, and Roger Darin, a Switzerland-based managing director responsible for the bank's Libor submissions, were both charged with conspiracy, the US Justice Department said. Hayes was also charged with wire fraud and a "price-fixing violation arising from his collusive activity with another bank to manipulate Libor". Mr Hayes' official naming followed his arrest last week by the Serious Fraud Office in connection with its own investigation into Libor-rigging. Two other men, both brokers in the City, were also arrested. [The Telegraph]America's two largest mortgage lenders could have lost more than $3bn (£1.85bn) as a result of banks' alleged manipulation of Libor. Fannie Mae and Freddie Mac, the giant US mortgage lenders, have been told they should consider suing banks amid allegations that several major financial institutions rigged key borrowing rates for several years. According to reports, the two lenders are likely to have lost several billions of dollars as a direct result of interest rates being artificially increased and decreased by banks. [The Telegraph]Next year will be "a make or break" year for Greece's future as a member of the eurozone, the country's finance minister has said, warning Europe's leaders that Athens still faces "the possible risk" of crashing out of the currency bloc. "We can make it next year if we can stick to the programme agreed with the EU and IMF," Yannis Stournaras said in an interview with the Financial Times. However, "the break would be if the political system finds the situation too difficult to handle", he added, referring to the danger of social unrest about austerity that could force the two left-of-centre parties to bring down the governing coalition. [Financial Times]GlaxoSmithKline has reached a $150m (£92m) preliminary settlement with US drug wholesalers who claimed the company improperly delayed entry to the market of generic alternatives to its nasal spray Flonase, according to court documents. The settlement was reached with, among others, AmerisourceBergen, Cardinal Health and McKesson Corp, who maintained that Glaxo had abused the citizen's petition process to maintain a market monopoly. [The Independent]The soap opera continued at Bumi yesterday after yet another board member was forced to resign from the conflict-riven Indonesian coal miner created by Nat Rothschild and the Bakrie family in November 2010. In a day of action, the Takeover Panel ruled that there was improper disclosure about the close relationship between two key shareholders - the Bakrie brothers and Rosan Roeslani - when the group was created by injecting the Bakries' Indonesian coal-mining assets into Mr Rothschild's listed cash shell. The Panel ruled yesterday that the two groups had acted "in concert" - and cut the voting power of their combined 57 per cent stake almost in half, to 29.9 per cent. [The Independent]BC
More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.